Investigating the Association of ApoE Genotypes with Blood-Brain Barrier Dysfunction Measured by Cerebrospinal Fluid-Serum Albumin Ratio in a Cohort of Patients with Different Types of Dementia

被引:18
作者
Karch, Andre [1 ,2 ]
Manthey, Henrike [1 ]
Ponto, Claudia [1 ]
Hermann, Peter [1 ]
Heinemann, Uta [1 ]
Schmidt, Christian [1 ]
Zerr, Inga [1 ]
机构
[1] Univ Hosp Gottingen, Clin Dementia Ctr, Dept Neurol, Gottingen, Germany
[2] Helmholtz Ctr Infect Res, Dept Epidemiol, Braunschweig, Germany
来源
PLOS ONE | 2013年 / 8卷 / 12期
关键词
ALZHEIMERS-DISEASE; APOLIPOPROTEIN-E; PERMEABILITY; CRITERIA;
D O I
10.1371/journal.pone.0084405
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background: Since more than a decade ApoE is known to be a strong risk factor for Alzheimer's disease (AD); however, molecular pathways mediating this risk are still unclear. In recent years it has been hypothesized that ApoE might play a role in the disintegration of blood-brain barrier (BBB). In the present study we addressed the question if ApoE genotypes might be associated with BBB function measured by albumin ratio (Q(Alb)) in a large cohort of patients with different types of dementia. Methods: Five hundred twenty (520) patients with Creutzfeldt-Jakob disease (CJD, n = 350), Alzheimer's disease (n = 71) and cerebral small vessel disease (n = 99) were assessed for their ApoE genotype. BBB function was measured in all patients using Q(Alb) and was compared between ApoE genotypes. Dominant and additive genetic models were assumed in order to investigate the potential effect of ApoE on BBB function. Results: We observed no systematic differences in Q(Alb) between ApoE genotypes within the present study. Increased Q(Alb) levels were shown for those without E3 allele in the subgroup of CJD patients when assuming a dominant genetic model (p = 0.035). This could not be confirmed for patients with other forms of dementia (p = 0.234). Discussion: Although there was some evidence for a protective effect of E3 alleles in CJD patients, this study does not support the hypothesis of a systematic role of ApoE genotypes in BBB function in individuals with a diagnosis of dementia. Thus, changes in BBB function do not seem to contribute to the increased risk of cognitive decline associated with certain ApoE genotypes. The interpretation of the results of this study must take into account that BBB function was only assessed by measuring Q(Alb) which has been shown to be a good marker for overall BBB integrity but might not reflect all qualities of the barrier.
引用
收藏
页数:6
相关论文
共 27 条
  • [1] Apolipoprotein E controls cerebrovascular integrity via cyclophilin A
    Bell, Robert D.
    Winkler, Ethan A.
    Singh, Itender
    Sagare, Abhay P.
    Deane, Rashid
    Wu, Zhenhua
    Holtzman, David M.
    Betsholtz, Christer
    Armulik, Annika
    Sallstrom, Jan
    Berk, Bradford C.
    Zlokovic, Berislav V.
    [J]. NATURE, 2012, 485 (7399) : 512 - 516
  • [2] Bickeboller H, 1997, AM J HUM GENET, V60, P439
  • [3] Blood-brain barrier impairment in Alzheimer disease - Stability and functional significance
    Bowman, G. L.
    Kaye, J. A.
    Moore, M.
    Waichunas, D.
    Carlson, N. E.
    Quinn, J. F.
    [J]. NEUROLOGY, 2007, 68 (21) : 1809 - 1814
  • [4] Apolipoprotein E and its receptors in Alzheimer's disease: pathways, pathogenesis and therapy
    Bu, Guojun
    [J]. NATURE REVIEWS NEUROSCIENCE, 2009, 10 (05) : 333 - 344
  • [5] ALZHEIMER'S DISEASE A breach in the blood-brain barrier
    Carmeliet, Peter
    De Strooper, Bart
    [J]. NATURE, 2012, 485 (7399) : 451 - 452
  • [6] Blood-Cerebrospinal Fluid Barrier Permeability in Alzheimer's Disease
    Chalbot, Sonia
    Zetterberg, Henrik
    Blennow, Kaj
    Fladby, Tormod
    Andreasen, Niels
    Grundke-Iqbal, Inge
    Iqbal, Khalid
    [J]. JOURNAL OF ALZHEIMERS DISEASE, 2011, 25 (03) : 505 - 515
  • [7] Is it appropriate to use albumin CSF/plasma ratio to assess blood brain barrier permeability?
    Chen, Ruo-Li
    [J]. NEUROBIOLOGY OF AGING, 2011, 32 (07) : 1338 - 1339
  • [8] The association of APOE genotype and cognitive decline in interaction with risk factors in a 65-69 year old community sample
    Christensen H.
    Batterham P.J.
    Mackinnon A.J.
    Jorm A.F.
    Mack H.A.
    Mather K.A.
    Anstey K.J.
    Sachdev P.S.
    Easteal S.
    [J]. BMC Geriatrics, 8 (1)
  • [9] Apolipoprotein E, amyloid-β, and blood-brain barrier permeability in Alzheimer disease
    Donahue, John E.
    Johanson, Conrad E.
    [J]. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2008, 67 (04) : 261 - 270
  • [10] Research criteria for the diagnosis of Alzheimer"s disease: revising the NINCDS-ADRDA criteria
    Dubois, Bruno
    Feldman, Howard H.
    Jacova, Claudia
    Dekosky, Steven T.
    Barberger-Gateau, Pascale
    Cummings, Jeffrey
    Delocourte, Andre
    Galasko, Douglas
    Gauthier, Serge
    Jicha, Gregory
    Meguro, Kenichi
    O'Brien, John
    Pasquier, Florence
    Robert, Philippe
    Rossor, Martin
    Solloway, Steven
    Stern, Yaakov
    Visser, Pieter J.
    Scheltens, Philip
    [J]. LANCET NEUROLOGY, 2007, 6 (08) : 734 - 746